- $68.48bn
- $73.07bn
- $9.26bn
- 98
- 20
- 75
- 70
Annual income statement for Zoetis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6,675 | 7,776 | 8,080 | 8,544 | 9,256 |
| Cost of Revenue | |||||
| Gross Profit | 4,630 | 5,483 | 5,630 | 6,020 | 6,542 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,679 | 5,288 | 5,424 | 5,608 | 6,123 |
| Operating Profit | 1,996 | 2,488 | 2,656 | 2,936 | 3,133 |
| Net Income Before Taxes | 1,996 | 2,488 | 2,656 | 2,936 | 3,133 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,636 | 2,034 | 2,111 | 2,340 | 2,496 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,638 | 2,037 | 2,114 | 2,344 | 2,486 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,638 | 2,037 | 2,114 | 2,344 | 2,486 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.49 | 4.39 | 4.57 | 5.16 | 5.55 |
| Dividends per Share |